Mihong Ren
Overview
Explore the profile of Mihong Ren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu K, Deng B, Jia T, Ren M, Chen H, Zhang J, et al.
Front Pharmacol
. 2025 Jan;
15:1510779.
PMID: 39881874
Background: (BC), also named Niuhuang in Chinese, is utilized as a resuscitation drug in Traditional Chinese Medicine (TCM) for the treatment of neurological disorders. Ischemic stroke (IS) is a significant...
2.
Ren M, Li Y, Yuan J, Wang J, Lu D, Xu Z, et al.
J Ethnopharmacol
. 2025 Jan;
342:119390.
PMID: 39880065
Ethnopharmacological Relevance: Bovis calculus (BC) has a medicinal history of over 2000 years in treating stroke in China. Bovis Culus Sativus (BCS) has similar pharmacological effects to BC. Due to...
3.
Xie Q, Lu D, Yuan J, Ren M, Li Y, Wang J, et al.
Phytother Res
. 2023 Jun;
37(9):4166-4184.
PMID: 37310024
Our previous study showed l-borneol reduced cerebral infarction in the acute stage after cerebral ischemia, but there is little about the study of subacute phase. We herein investigated the cerebral...
4.
Ma R, Lu D, Xie Q, Yuan J, Ren M, Li Y, et al.
Phytomedicine
. 2023 Jan;
109:154583.
PMID: 36610167
Background: The Chinese medicines Borneolum and l-Borneolum have neuroprotective effects on acute cerebral ischaemia-reperfusion (IR) in rats. Research on their effects during recovery from cerebral IR is lacking. Cerebral ischaemia...
5.
Li J, Yuan J, Li Y, Wang J, Xie Q, Ma R, et al.
Phytomedicine
. 2022 Aug;
106:154411.
PMID: 36030746
Background: d-Borneol has been widely used as a drug absorption enhancer, but there are few studies on the anti-resistance ability of d-borneol combined with cisplatin in cisplatin-resistant non-small cell lung...
6.
Li J, Yuan J, Li Y, Wang J, Gong D, Xie Q, et al.
Cell Mol Biol Lett
. 2022 Aug;
27(1):68.
PMID: 35982418
No abstract available.
7.
Li J, Yuan J, Li Y, Wang J, Gong D, Xie Q, et al.
Cell Mol Biol Lett
. 2022 Jul;
27(1):61.
PMID: 35883026
Background: Cisplatin (CDDP) is commonly used to treat non-small cell lung cancer (NSCLC), but the appearance of drug resistance greatly hinders its efficacy. Borneol may promote drug absorption; however, synergism...
8.
Xie Q, Li H, Ma R, Ren M, Li Y, Li J, et al.
Phytomedicine
. 2022 Jan;
97:153927.
PMID: 35030387
Background: In folk medicine Coptis chinensis Franch (Huanglian in Chinese, HL) and Magnoliae officinalis (Houpo, HP) have been used to treat gastrointestinal disorders over hundreds of years, such as ulcers...
9.
Xu Z, Lu D, Yuan J, Ren M, Ma R, Xie Q, et al.
Front Pharmacol
. 2021 Dec;
12:785598.
PMID: 34916951
In recent years, the incidence and mortality of cardio-cerebrovascular diseases have been increasing year by year, which has become global burden and challenge. Based on the holistic thinking of "brain...
10.
Li J, Xie Q, Ma R, Li Y, Yuan J, Ren M, et al.
Front Med (Lausanne)
. 2021 Dec;
8:750170.
PMID: 34901063
Borneol, a traditional Chinese medicine, can enhance therapeutic efficacy by guiding the active ingredients to the target site. Reportedly, borneol improves the penetration capacity of the nasal, cornea, transdermal, intestinal,...